Matsukage A, Tanabe K, Yamaguchi M, Taguchi Y N, Nishizawa M, Takahashi T, Takahashi T
Biochim Biophys Acta. 1981 Oct 27;655(3):269-77. doi: 10.1016/0005-2787(81)90037-x.
Mouse myeloma DNA polymerase gamma was extensively purified to a final specific activity of 156 000 units (nmol dTMP incorporation per h) per mg protein on (rA)n.(dT)12-18 as a template primer. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of protein fractions obtained by DNA-cellulose column chromatography revealed that the amount of a polypeptide of Mr = 47 000 changed proportionally with DNA polymerase gamma activity. A minor polypeptide of Mr = 140 000 also seemed to change with the enzyme activity, but other polypeptides did not. Analysis by 125I-labeled peptide mapping indicates that the Mr 47 000 polypeptide in the mouse myeloma DNA polymerase gamma preparation is structurally related to the Mr 47 000 polypeptide of chick embryo DNA polymerase gamma (Yamaguchi, M., Matsukage, A. and Takahashi, T. (1980) J. Biol. Chem. 255, 7002-7009). An antibody against chick embryo DNA polymerase gamma cross-reacted with the mouse enzyme, indicating a structural relationship between avian and murine enzymes. Since the Mr 47 000 polypeptide accounts for 31.4% of total protein in the purified preparation, the specific activity is estimated to be about 490 000 units per mg of the Mr 47 000 polypeptide. The rate of poly(dT) elongation by the purified enzyme was 1 260 per nucleotides per min. This value is in the same range as the turnover number (1 530 nucleotides per min per enzyme molecule) which is calculated from the 'expected' specific activity with respect to the Mr 47 000 polypeptide and the molecular weight (Mr = 188 000 on the assumption of a tetrameric structure of the Mr 47 000 polypeptide). Results indicate that the Mr 47 000 polypeptide is a component of the mouse myeloma DNA polymerase gamma.
小鼠骨髓瘤DNA聚合酶γ被广泛纯化,以(rA)n·(dT)12 - 18作为模板引物时,最终比活性达到每毫克蛋白质156000单位(每小时掺入dTMP的纳摩尔数)。通过DNA - 纤维素柱色谱获得的蛋白质组分进行十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳显示,分子量为47000的一种多肽的量与DNA聚合酶γ活性成比例变化。分子量为140000的一种次要多肽似乎也随酶活性变化,但其他多肽则不然。125I标记的肽图谱分析表明,小鼠骨髓瘤DNA聚合酶γ制剂中分子量为47000的多肽在结构上与鸡胚DNA聚合酶γ分子量为47000的多肽相关(山口,M.,松影,A.和高桥,T.(1980年)《生物化学杂志》255,7002 - 7009)。针对鸡胚DNA聚合酶γ的抗体与小鼠酶发生交叉反应,表明禽类和鼠类酶之间存在结构关系。由于分子量为47000的多肽占纯化制剂中总蛋白的31.4%,估计其比活性约为每毫克分子量为47000的多肽490000单位。纯化酶催化聚(dT)延伸的速率为每分钟每核苷酸1260个。该值与根据分子量为47000的多肽的“预期”比活性和分子量(假设分子量为47000的多肽为四聚体结构,分子量 = 188000)计算出的转换数(每分钟每个酶分子1530个核苷酸)处于同一范围。结果表明,分子量为47000的多肽是小鼠骨髓瘤DNA聚合酶γ的一个组分。